About Us
About Carna
Management
Our Business
Products & Services
Products
Kinase Proteins and Other Protein Products
Assay Kits
Services
Activity-based Biochemical Screening/Profiling Assay Services
Cell-based Assay Services
Pricing & Technical Inquiry
Drug Discovery
Pipeline
Science
Technology
Partnering
Investors
News
Financial Reports/Presentations
Financial Highlights
IR Schedule
IR Contact
JP
EN
JP
EN
Kinase Inhibitor Discovery
with an untiring quest for future therapeutics
Our Business
Products & Services
Drug Discovery
Latest News
Dec 11, 2023
Investors
Carna announces a poster presentation on design of ongoing Phase 1b study for its non-covalent BTK inhibitor AS-1763 at American Society of Hematology Annual Meeting
Dec 11, 2023
Investors
Carna announces a poster presentation featuring preclinical characterization of its non-covalent BTK inhibitor AS-1763 at American Society of Hematology Annual Meeting
Nov 07, 2023
Investors
FY2023 Q3 Presentation
Nov 07, 2023
Investors
Consolidated Financial Results for the Third Quarter of the Year Ending December 31, 2023
Nov 06, 2023
Investors
Carna announces acceptance of two posters on AS-1763 for presentation at ASH Annual Meeting
Nov 01, 2023
Investors
Carna Announces Positive Results from the Phase 1 MAD study of Sofnobrutinib (AS-0871)
Oct 23, 2023
Investors
Carna Announces International Nonproprietary Names Selection for AS-0871 and AS-0141
Oct 16, 2023
Investors
Announcement of Clinical Trials.gov Registration for GS-9911 Phase 1 Study
About Us
Investors
Investor Contact
Products & Services Contact